Fidelity's passive stake remains unchanged at 15.0%, indicating no material conviction shift. Monitor next 13F filing for any position changes and watch for any conversion to 13D if Fidelity's intent changes.
GPCR drugs
GPCR drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $19.08entry
- T+1 · 11d ago +6.66%α +6.34% · $20.35
- T+5 · 5d ago +3.98%α +0.69% · $19.84
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 32,089,434 shares of Structure Therapeutics Inc. (GPCR) as of September 30, 2026, representing 15.0% of outstanding common stock. This is a routine passive stake update with no change in the reported percentage from the prior filing, indicating Fidelity maintained its position.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 32,089,434 shares of GPCR common stock as of September 30, 2026.
- The stake represents 15.0% of outstanding shares.
- This is an amendment to Schedule 13G, confirming passive investment intent.
- The filing date is November 5, 2026, with a beneficial ownership date of September 30, 2026.
Financial Impact
No change in stake percentage; Fidelity continues to hold 15.0% of GPCR.
Risk Factors
- No material risks identified from this routine passive stake update.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002858 |
| Document: 0000315066-26-002858-index-headers.html | 0000315066-26-002858 |
| Document: 0000315066-26-002858-index.html | 0000315066-26-002858 |
| Document: 0000315066-26-002858.txt | 0000315066-26-002858 |
Track record
10 reports on GPCR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $19.16 Now $18.57 −3.08% settles Feb 12
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $21.73 Now $18.57 −14.54% settles Feb 8
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $19.08 Now $18.57 −2.67% settles Feb 3
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $43.30 to $47.34 Now $18.57 +57.11% ▼ −9.33% −4.93% vs SPY
- May 7, 202627w ago 8-K Mixed 6/10 Entry $39.10 to $49.64 Now $18.57 −52.51% ▲ +26.96% +22.12% vs SPY
- Apr 27, 202629w ago Press Release Neutral 2/10 Entry $43.56 to $50.80 Now $18.57 −57.37% ▲ +16.62% +12.63% vs SPY
- Apr 15, 202630w ago 8-K Neutral 3/10 Entry $54.25 to $53.36 Now $18.57 −65.77% ▼ −1.64% −9.78% vs SPY
- Mar 16, 202635w ago Press Release Bullish 8/10 Entry $56.65 to $37.77 Now $18.57 −67.22% ▼ −33.33% −43.81% vs SPY
- Feb 28, 202637w ago Institutional Cluster Mixed 6/10 Entry $62.90 to $39.58 Now $18.57 −70.48% ▼ −37.07% −46.40% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers